Drug Discovery for Kinetoplastid Diseases: Future Directions

Rao, Srinivasa P. S.; Barrett, Michael P.; Dranoff, Glenn; Faraday, Christopher J.; Gimpelewicz, Claudio R.; Hailu, Asrat; Jones, Catherine L.; Kelly, John M.; Lazdins-Helds, Janis K.; Mäser, Pascal; Mengel, Jose; Mottram, Jeremy C.; Mowbray, Charles E.; Sacks, David L.; Scott, Phillip; Späth, Gerald F.; Tarleton, Rick L.; Spector, Jonathan M.; Diagana, Thierry T..
Artículo en Inglés | ARCA | ID: arc-35252

Documentos relacionados

  1. [Insights into the Pathogenesis of Inflammatory Bowel Diseases: Genetics and Microbiota].
  2. [Occupational obstructive airway diseases: How can early diagnosis be made to avoid chronic courses?]
  3. [Evidence-based health care with pharmaceuticals for rare diseases: the role of digitalisation].
  4. [Drug-induced interstitial lung diseases: often forgotten].
  5. Public health threat of novel zoonotic diseases: literature review.
  6. [Vitreomacular Interface Diseases: Vitreomacular Adhesion, Vitreomacular Traction, Epiretinal Membranes, and Macular Hole].
  7. [Foregut diseases: foregut neoplasms].
  8. Adeno-associated virus-mediated gene therapy for rare pediatric neurogenetic diseases: Current status and outlook.
  9. [MRI diagnostics in inflammatory joint and spinal diseases: protocols and special sequences: when and for what?]
  10. [The medical informatics initiative and rare diseases: next-generation routine data for diagnosis, therapy selection and research].